Life Sciences
HIMSS21
Naomi Fried, founder and CEO of PharmStars, discusses how her company mentors digital health startups and coaches pharma executives to prepare both parties for successful partnerships.
This comes ahead of the company's reported IPO filing by October.
Humanizing technology will help drive personalized medicine, says Dr. Risto Miettunen, president of the International Hospital Federation.
2bPrecise CEO Assaf Halevy discusses how genomic information can be injected into the workflow to manage the treatment of the patient.
Symmetric Health Solutions CEO Rich Kucera and Northern Light's Matt Marston discuss how COVID-19 has affected the supply chain as well as Northern Light's successful vaccine rollout.
Moving from one-size-fits-all to personalized drug dosing can increase the efficacy and safety of medications, claims InsightRX CEO Sirj Goswami.
Dr. Charles Tuchinda, EVP and deputy group head of Hearst Health, offers best practices for those using decision support IT for prescribing meds.
First Databank has adjusted its own editorial practices as evidence of coronavirus drugs and treatment continues to evolve, explains Director of Product Management Anna Dover.
Pharmas are becoming more interested in patients' personal experiences and their input, says Kevin Freiert, principal of Salem Oaks Consulting.